HUTCHMED (China) Ltd HCM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HCM is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- GBX 304.00
- Day Range
- GBX 286.90–312.00
- 52-Week Range
- GBX 173.60–338.00
- Bid/Ask
- GBX 0.00 / GBX 0.00
- Market Cap
- GBX 247.56 Bil
- Volume/Avg
- 117,319 / 82,556
Key Statistics
- Price/Earnings (Normalized)
- 31.42
- Price/Sales
- 3.74
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.13%
Company Profile
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,990
- Website
- https://www.hutch-med.com
Comparables
Valuation
|
Metric
|
HCM
|
09926
|
06628
|
|---|---|---|---|
Price/Earnings (Normalized) | 31.42 | 19.87 | — |
Price/Book Value | 4.32 | 7.81 | 0.77 |
Price/Sales | 3.74 | 8.15 | 12.16 |
Price/Cash Flow | 21.15 | 14.94 | — |
Price/Earnings
HCM
09926
06628
Financial Strength
|
Metric
|
HCM
|
09926
|
06628
|
|---|---|---|---|
Quick Ratio | 2.58 | 5.46 | 1.50 |
Current Ratio | 2.72 | 6.43 | 1.61 |
Interest Coverage | 30.20 | 26.84 | −33.53 |
Quick Ratio
HCM
09926
06628
Profitability
|
Metric
|
HCM
|
09926
|
06628
|
|---|---|---|---|
Return on Assets (Normalized) | 11.29% | 24.23% | −22.79% |
Return on Equity (Normalized) | 19.17% | 44.26% | −38.31% |
Return on Invested Capital (Normalized) | 13.58% | 29.66% | −26.22% |
Return on Assets
HCM
09926
06628
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Wfvgpkfhg | Ylj | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Dpjpdmny | Ysqdyy | $70.8 Bil | |
HLN
| Haleon PLC ADR | Ckvfczfr | Qrfc | $38.2 Bil | |
VTRS
| Viatris Inc | Lgmkkhmz | Qxbb | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Svlclch | Jkwqm | $12.5 Bil | |
CTLT
| Catalent Inc | Wxbmpgpf | Zsljhbp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Mcblsdzm | Wdpr | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Mtdtlwwv | Thk | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Chzsqfxj | Frdttds | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Zwhfrmgv | Fzx | $2.9 Bil |